Pazopanib Hydrochloride

Spezifikationen

635702-64-6CAS-Nummer

619-728-0EG-Nummer

5-[[4-[(2,3-dimethylindazol-6-yl)-methylamino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide;hydrochlorideIUPAC-Name

C21H24ClN7O2SChemische Formel

474 g/molMolekulargewicht

Pazopanib hydrochloride; 635702-64-6; pazopanib HCl; UNII-33Y9ANM545; pazopanib monohydrochloride; Pazopanib (as hydrochloride); 33Y9ANM545; 5-((4-((2,3-DIMETHYL-2H-INDAZOL-6-YL)(METHYL)AMINO)PYRIMIDIN-2-YL)AMINO)-2-METHYLBENZENESULFONAMIDE HYDROCHLORIDE; CHEBI:71217; DTXSID70212956; NSC737754; 5-((4-((2,3-Dimethyl-2H-indazol-6-yl)methylamino)pyrimidin-2-yl)amino)-2-methylbenzenesulfonamide monohydrochloride; 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide hydrochloride; Benzenesulfonamide, 5-((4-((2,3-dimethyl-2H-indazol-6-yl)methylamino)-2-pyrimidinyl)amino)-2-methyl-, monohydrochloride; PAZOPANIB HYDROCHLORIDE (MART.); PAZOPANIB HYDROCHLORIDE [MART.]; 5-({4-[(2,3-dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzenesulfonamide hydrochloride; 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)methylamino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide monohydrochloride; RefChem:55813; DTXCID00135447; 5-((4-((2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-yl)amino)-2-methylbenzenesulfonamide monohydrochloride; Votrient; Pazopanib (Hydrochloride); Pazopanib HCl (GW786034 HCl); GW786034B; GW-786034B; MFCD12546138; GW786034 (Hydrochloride); 5-[[4-[(2,3-dimethylindazol-6-yl)-methylamino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide;hydrochloride; S1035; GW 786034; Armala; 5-{4-[(2,3-Dimethyl-2H-indazol-6-yl)-methyl-amino]-pyrimidin-2-ylamino}-2-methyl-benzenesulfonamide hydrochloride; Patorma; GW786034 HCl; Votrient (TN); Pazopanib hydrochloride [USAN:JAN]; Pazopanib Hydrochloride?; C21H24ClN7O2S; MLS004774147; Pazopanib, Hydrochloride Salt; SCHEMBL159487; orb1224395; orb1300336; Pazopanib Hydrochloride [USAN]; CHEMBL1201733; SCHEMBL29386934; EX-A956; MQHIQUBXFFAOMK-UHFFFAOYSA-N; Pazopanib HCl (GW786034 ); GLXC-90208; HMS5079O05; Pazopanib HCl - Bio-X trade mark; Pazopanib hydrochloride (JAN/USAN); PAZOPANIB HYDROCHLORIDE [MI]; EBC-67069; PAZOPANIB HYDROCHLORIDE [JAN]; AKOS015958593; CCG-269485; CS-0126; FD71644; GSK-786034; KS-1458; NSC-737754; PB31655; SB10367; PAZOPANIB HYDROCHLORIDE [WHO-DD]; AC-24726; BP166746; HY-12009; SMR003500790; P2243; PAZOPANIB HYDROCHLORIDE [ORANGE BOOK]; SW218082-2; D05380; F519777; Q27888072; 5-({4-[(2,3-dimethyl-2H-indazol-6-yl)(methyl)amino]-2-pyrimidinyl}amino)-2-methylbenzenesulfonamide Hydrochloride; 5-({4-[(2,3-dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzene-1-sulfonamide hydrochloride; 5-({4-[(2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzene-1-sulfonamide--hydrogen chloride (1/1); 5-[[4-[(2,3-dimethylindazol-6-yl)-methyl-amino]pyrimidin-2-yl]amino]-2-methyl-benzenesulfonamide;hydrochloride; 5-[[4-[(2,3-dimethylindazol-6-yl)-methylamino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide hydrochloride; Benzenesulfonamide, 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-, hydrochloride (1:1)Synonyme